Serving clients throughout PA, NJ, NY, and MD. If you took Ozempic, Wegovy, Mounjaro, or another GLP-1 medication and suddenly lost vision in one or both eyes — diagnosed as NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) — you may have a claim separate from the gastroparesis litigation. Siddons Law Firm is reviewing GLP-1 vision loss claims. Call (610) 255-7500.
Key Takeaways
- A separate federal MDL (MDL 3176) was established in December 2025 specifically for GLP-1 vision loss (NAION) claims.
- Nearly 2,947 lawsuits have been filed by patients who experienced sudden vision loss after using Ozempic, Wegovy, Mounjaro, Rybelsus, Saxenda, or Zepbound.
- NAION is a devastating stroke-like event in the optic nerve that typically leaves patients with permanent partial or complete blindness in the affected eye.
- Manufacturers include Novo Nordisk (Ozempic, Wegovy, Rybelsus, Saxenda) and Eli Lilly (Mounjaro, Zepbound).
- Free case review. No fee unless we recover.
Who May Qualify
- You used a GLP-1 or GLP-1/GIP agonist — Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, or Saxenda — for at least one month.
- You experienced sudden painless vision loss in one or both eyes.
- An ophthalmologist diagnosed you with NAION, anterior ischemic optic neuropathy, or optic nerve infarction.
- Your diagnosis occurred after you began the medication.
Compensation Available
- Past and future medical expenses — ophthalmology, neuro-ophthalmology, vision rehabilitation
- Lost wages and reduced earning capacity (especially for drivers, pilots, and visually demanding occupations)
- Pain and suffering and loss of enjoyment of life
- Loss of consortium for spouses
- Punitive damages
Why Choose Our Firm
Siddons Law Firm represents GLP-1 vision loss clients throughout Pennsylvania, New Jersey, New York, and Maryland. We partner with nationally recognized MDL co-counsel in MDL 3176 — your claim is backed by neuro-ophthalmology experts, pharmacoepidemiologists, and trial lawyers who also sit on the GLP-1 gastroparesis MDL (MDL 3094). No up-front costs.
Frequently Asked Questions
I have a gastroparesis claim too. Can I file both?
Yes. The vision loss and gastroparesis claims are handled in separate MDLs, and plaintiffs can pursue both.
Is my prescription for diabetes vs. weight loss relevant?
No. The same active ingredient causes the same injury regardless of FDA-approved indication. All GLP-1 users who developed NAION may qualify.
My vision partially returned. Do I still have a claim?
Yes. Any documented NAION event qualifies regardless of final vision outcome.
Start Your GLP-1 Vision Loss Case
Call (610) 255-7500 or email msiddons@siddonslaw.com. Free case review. Serving clients throughout PA, NJ, NY, and MD.